Page last updated: 2024-11-03

ono 1078 and Pancreatic Diseases

ono 1078 has been researched along with Pancreatic Diseases in 1 studies

pranlukast: SRS-A antagonist; leukotriene D4 receptor antagonist

Pancreatic Diseases: Pathological processes of the PANCREAS.

Research Excerpts

ExcerptRelevanceReference
"Acute pancreatitis was induced in rats by intravenous infusion of a supramaximal dose of cerulein (5 micrograms/kg h for 4 h)."1.30Peptide leukotriene receptor antagonist diminishes pancreatic edema formation in rats with cerulein-induced acute pancreatitis. ( Hirano, T, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hirano, T1

Other Studies

1 other study available for ono 1078 and Pancreatic Diseases

ArticleYear
Peptide leukotriene receptor antagonist diminishes pancreatic edema formation in rats with cerulein-induced acute pancreatitis.
    Scandinavian journal of gastroenterology, 1997, Volume: 32, Issue:1

    Topics: Acute Disease; Amylases; Animals; Body Water; Cathepsin B; Ceruletide; Chromones; Edema; Leukotriene

1997